r/valueinvesting
Opened these positions over the past weeks
Author details value investing rationale for accumulating ADBE, CRM, NOW, SAP, RELX, WKL, PEGA, MSFT, PYPL, NKE, ADYEN, NVO, and ABT.
- Multiple high-quality companies are trading at attractive valuations or discounts to historical multiples.
- AI integration in enterprise software is driving real revenue growth and reducing churn rather than causing disruption.
- Strong competitive moats, pricing power, and embedded workflows provide downside protection and long-term stability.
Been quietly accumulating over the past few weeks across different segments.
ADBE: The narrative that AI kills Adobe ignores that Adobe is integrating AI aggressively into its products. The fact that this is trading at a discount to its historical multiples while having a strong AI revenue ramp seems like a temporary market inefficiency.
CRM: Agentforce is early but real. Salesforce has the enterprise relationships and the distribution to make AI agents stick.
NOW: ServiceNow has pricing power, sticky enterprise contracts, and AI integration that actually reduces churn rather than risking it.
SAP: Less talked about than US peers but the business transformation is real and the valuation is more forgiving.
RELX: Customers don’t leave these platforms easily. Goldman Sachs recently added it to the buy list and the company started a buyback program.
WKL: Same as RELX. Deeply embedded in accounting, legal, and compliance workflows.
PEGA: Trading well below intrinsic value in my view.
MSFT: My fav stock to own since day 1. Love to see these levels.
PYPL: Branded checkout is stabilizing, margins are improving, and you’re paying a very modest multiple for a network with over 400 million active accounts.
NKE: I know Nike has had real execution issues but the brand is structurally intact and the new CEO is making the right moves on direct to consumer.
ADYEN: One of the highest quality fintech businesses in Europe. Volume growth is back on track and the long term positioning in enterprise payments is as strong as ever.
NVO: Yes GLP 1 competition is real and the valuation has reset accordingly. But Novo Nordisk’s pipeline, manufacturing scale advantages, and brand in obesity/diabetes make this a very different risk reward than the market is pricing.
ABT: Steady, diversified healthcare business that gets overlooked.
Curious what you guys think about these picks. Particularly interested in pushback on the AI disruption for the software companies.
How much are you down ytd?
Everthing below 50% is a win i guess
Yeah its crazy i own wkl Adyen and now aswell the only thing keeping my ytd up is the ia trade lol
Haha, yeah, same for me. Overall I’m up YTD thanks to all the AI picks and Big Data and AI focused ETFs
Bagholders Anonmyous should be the name of this sub lol
I highly doubt you have a deep understanding of every company you bought. Who has time to follow and research all of them? Many hedge funds don't even have as many positions and you have over a dozen that only accounts for small portion of your portfolio.
Seriously what's the point?
Why buy stocks that are going up, when you can buy stuff that keeps going down!
That’s 13 companies….. you seriously couldn’t pick between those 13? There have to be one or 2 that have better numbers or you like better. 13 is a full portfolio, there’s no way you like them equally. And if it is your whole portfolio then it’s horribly diversified .
Of the list there are about 3-4 I don’t know about, 2 I like (Abbt and now) 3 I’ve looked at and I wouldn’t touch (nke, pypl, nvo )…. And the rest are “fine” at best
Look it’s your money and I may be completely wrong, so do what you think is best, but that feels like a real ugly portfolio
I get your point, though I’m not really giving any context about my portfolio allocation. The vast majority (\~80%) of my money is in ETFs/index funds. But I also like buying individual stocks when I think the market is wrong. So the stocks mentioned in this post are part of that portion of my portfolio, among others ofcourse.